BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10515315)

  • 1. Effects of a novel fentanyl derivative on drug discrimination and learning in rhesus monkeys.
    Gerak LR; Moerschbaecher JM; Bagley JR; Brockunier LL; France CP
    Pharmacol Biochem Behav; 1999 Oct; 64(2):367-71. PubMed ID: 10515315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of a deuterium-substituted mirfentanil derivative, OHM10579, in rhesus monkeys.
    Lelas S; Gerak LR; Landers LK; Brandt MR; Bagley JR; Brockunier LL; France CP
    Pharmacol Biochem Behav; 1998 Jul; 60(3):665-75. PubMed ID: 9678650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
    France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
    Negus SS; Gatch MB; Mello NK
    Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
    Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
    France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys.
    Negus SS; Mello NK
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):307-17. PubMed ID: 10609965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects and binding affinities of the fentanyl derivative OHM3507.
    France CP; Ahn SC; Brockunier LL; Bagley JR; Brandt MR; Winsauer PJ; Moerschbaecher JM
    Pharmacol Biochem Behav; 1998 Feb; 59(2):295-303. PubMed ID: 9476973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment.
    Gauthier CA; Gerak LR; Bagley JR; Brockunier LL; France CP
    Psychopharmacology (Berl); 1998 May; 137(1):67-73. PubMed ID: 9631958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids.
    Broadbent J; Gaspard TM; Dworkin SI
    Pharmacol Biochem Behav; 1995; 51(2-3):379-85. PubMed ID: 7667357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
    Bowen CA; Fischer BD; Mello NK; Negus SS
    J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
    France CP; de Costa BR; Jacobson AE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1990 Feb; 252(2):600-4. PubMed ID: 2156055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability.
    Negus SS; Schrode K; Stevenson GW
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):386-99. PubMed ID: 18837635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.